Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Symptomatic case 19% Improvement Relative Risk Case -6% Case (b) -22% c19hcq.org Shabani et al. HCQ for COVID-19 PEP Is post-exposure prophylaxis with HCQ beneficial for COVID-19? Prospective study of 113 patients in Iran Study underpowered to detect differences Shabani et al., Pulmonary Pharmacology & Therape.., doi:10.1016/j.pupt.2021.102069 Favors HCQ Favors control
Evaluation of the Prophylactic Effect of Hydroxychloroquine on People in Close-Contact with Patients with Covid-19
Shabani et al., Pulmonary Pharmacology & Therapeutics, doi:10.1016/j.pupt.2021.102069
Shabani et al., Evaluation of the Prophylactic Effect of Hydroxychloroquine on People in Close-Contact with Patients with.., Pulmonary Pharmacology & Therapeutics, doi:10.1016/j.pupt.2021.102069
Aug 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Small PEP trial with 51 HCQ patients, not showing a significant difference in cases. IRCT20130917014693N10.
risk of symptomatic case, 19.0% lower, RR 0.81, p = 1.00, treatment 2 of 51 (3.9%), control 3 of 62 (4.8%), NNT 109, day 7.
risk of case, 6.4% higher, RR 1.06, p = 1.00, treatment 7 of 51 (13.7%), control 8 of 62 (12.9%), day 7, PCR+ and symptomatic.
risk of case, 21.6% higher, RR 1.22, p = 0.78, treatment 7 of 51 (13.7%), control 7 of 62 (11.3%), day 7, PCR+ only.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Shabani et al., 10 Aug 2021, prospective, Iran, peer-reviewed, 16 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Journal Pre-proof Evaluation of the Prophylactic Effect of Hydroxychloroquine on People in CloseContact with Patients with Covid-19 Minoosh Shabani, Mehdi Totonchi, Omidvar Rezaeimirghaed, Latif Gachkar, Mohammadreza Hajiesmaeili, Ali Khoshkar, Mahdi Amirdosara, Ali Saffaei, Shervin Shokouhi, Masoud Mardani, Ilad Alavi Darazam, Alireza Karami, Milad Sharifi, Mana Zaman, Elham Abedheydari, Zahra Sahraei PII: S1094-5539(21)00081-X DOI: https://doi.org/10.1016/j.pupt.2021.102069 Reference: YPUPT 102069 To appear in: Pulmonary Pharmacology & Therapeutics Received Date: 9 February 2021 Revised Date: 4 August 2021 Accepted Date: 7 August 2021 Please cite this article as: Shabani M, Totonchi M, Rezaeimirghaed O, Gachkar L, Hajiesmaeili M, Khoshkar A, Amirdosara M, Saffaei A, Shokouhi S, Mardani M, Darazam IA, Karami A, Sharifi M, Zaman M, Abedheydari E, Sahraei Z, Evaluation of the Prophylactic Effect of Hydroxychloroquine on People in Close-Contact with Patients with Covid-19, Pulmonary Pharmacology & Therapeutics, https:// doi.org/10.1016/j.pupt.2021.102069. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2021 Published by Elsevier Ltd. Minoosh Shabani Barzegar: Conceptualization, Methodology, Investigation, Data Curation, Writing - Original Draft, Writing - Review & Editing, Project administration Mehdi Totonchi: Conceptualization, Data Curation, Formal analysis Writing - Review & Editing Omidvar Rezaeimirghaed: Conceptualization, Data Curation, Writing - Review & Editing Latif Gachkar: Conceptualization, Data Curation, Writing - Review & Editing Mohammadreza Hajiesmaeili: Conceptualization, Data Curation, Writing - Review & Editing Ali Khoshkar: Conceptualization, Data Curation, Writing - Review & Editing oo f Mahdi Amirdosara: Conceptualization, Data Curation, Writing - Review & Editing Ali Saffaei: Conceptualization, Data Curation, Formal analysis, Writing - Review & Editing re -p r Shervin Shokouhi: Conceptualization, Data Curation, Writing - Review & Editing Masoud Mardani: Conceptualization, Data Curation, Writing - Review & Editing lP Ilad Alavi Darazam: Conceptualization, Data Curation, Writing - Review & Editing Alireza Karami: Conceptualization, Data Curation, Writing - Review & Editing ur na Milad Sharifi: Conceptualization, Data Curation, Writing - Review & Editing Mana Zaman: Conceptualization, Data Curation, Writing - Review & Editing Jo Elham Abedheydari: Conceptualization, Data Curation, Writing - Review & Editing Zahra Sahraei: Conceptualization, Methodology, Investigation, Data Curation, Writing Original Draft, Writing - Review & Editing, Supervision Evaluation of the Prophylactic Effect of Hydroxychloroquine on People in Close-Contact with Patients with Covid-19 Minoosh Shabani a,b,§, Mehdi Totonchic,d,§ , Omidvar Rezaeimirghaed e , Latif Gachkar a,b, Mohammadreza Hajiesmaeili f , Ali Khoshkar g , Mahdi Amirdosara f , Ali Saffaei h , Shervin Shokouhi a,b, Masoud Mardani a,b , Ilad..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit